Plague in China 2014-All sporadic case report of pneumonic plague

BMC Infectious Diseases

Volumn 16, Issue 1, 2016, Pages

  Li, Yun fang ^a   Li, De biao ^b   Shao, Hong sheng ^d   Li, Hong jun ^a   Han, Yue dong ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Radiology Department   (China)

^c LANZHOU GENERAL HOSPITAL   (China)

^d Department of Interventional Radiology   (China)

Author keywords

Clinical feature; Diagnosis; Plague; Quarantine; Treatment

Indexed keywords

CEFOPERAZONE; CLINDAMYCIN; GENTAMICIN; STREPTOMYCIN; SULBACTAM; SULFADIAZINE;

ACUTE KIDNEY FAILURE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIBODY TITER; ARTICLE; BIOSAFETY; BRAIN DISEASE; CASE REPORT; CHINA; COUGHING; CURTOBACTERIUM; DISSEMINATED INTRAVASCULAR CLOTTING; DYSPNEA; ELECTROLYTE DISTURBANCE; FEVER; HEART ARRHYTHMIA; HEMAGGLUTINATION TEST; HUMAN; HYPOXEMIA; INFECTION CONTROL; LIVER INJURY; LUNG INFECTION; MALE; MIDDLE AGED; NASOPHARYNGEAL ASPIRATION; NONHUMAN; OXYGEN THERAPY; PARTIAL THROMBOPLASTIN TIME; PASTORAL DOG; PLAGUE; PNEUMONIC PLAGUE; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEPTIC SHOCK; SEROLOGY; SPUTUM ANALYSIS; THORAX RADIOGRAPHY; UNCONSCIOUSNESS; YERSINIA PESTIS; COMPLICATION; FATALITY;

ADULT; CHINA; FATAL OUTCOME; HUMANS; MALE; MIDDLE AGED; PLAGUE;

EID: 84958546083     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/s12879-016-1403-8     Document Type: Article

References (42)

1. Wilschut LI, Addink EA, Heesterbeek H, Heier L, Laudisoit A, Begon M, et al. Potential corridors and barriers for plague spread in Central Asia. Int J Health Geogr. 2013;12:49-64.
2. Qian Q, Zhao J, Fang L, Zhou H, Zhang W, Wei L, et al. Mapping risk of plague in Qinghai-Tibetan Plateau, China. BMC Infect Dis. 2014;14:382.
3. Stenseth NC, Atshabar BB, Begon M, Belmain SR, Bertherat E, Carniel E, et al. Plague: past present and future. PLoS Med. 2008;5(1), E3.
4. Tan J, Liu Y, Shen E, Zhu W, Wang W, Li R, et al. Plague Foci of the World. The Atlas of Plague and Its Environment in the People's Republic of China. Beijing: Science press; 2000. p. 42-6. 4.
5. World Health Organization. Plague. Media centre. Available at http://www.who.int/mediacentre/factsheets/fs267/en/. Updated November 2014.
6. National Health and Family Planning Commission of the People's Republic of China. http://www.nhfpc.gov.cn/zhuzhan/yqxx/lists.shtml.
7. Rollins SE, Rollins SM, Ryan ET. Yersinia pestis and the plague. Am J Clin Pathol. 2003;119 Suppl 1:S78-85.
8. Suzuki S, Hotta S. Antiplague antibodies against Yersinia pestis fraction-I antigen in serum from rodents either experimentally infected or captured in harbor areas of Japan, 1971-1977. Microbiol Immunol. 1979;23(12):1157-68.
9. Wang T, Qi Z, Wu B, Zhu Z, Yang Y, Cui B, et al. A new purification strategy for fraction 1 capsular antigen and its efficacy against Yersinia pestis virulent strain challenge. Protein Expr Purif. 2008;61(1):7-12.
10. Wang H, Cui Y, Wang Z, Wang X, Guo Z, Yan Y, et al. A dog-associated primary pneumonic plague in Qinghai Province, China. Clin Infect Dis. 2011;52(2):185-90.
11. Tsukano H, Wake A, Sakakibara Y. Plasmid-like properties of the four virulence-associated factors of Yersinia pestis. Microbiol Immunol. 1986;30(9):837-48.
12. Hinnebusch J, Schwan TG. New method for plague surveillance using polymerase chain reaction to detect Yersinia pestis in fleas. J Clin Microbiol. 1993;31(6):1511-4.
13. Smego RA, Frean J, Koornhof HJ. Yersiniosis I: microbiological and clinicoepidemiological aspects of plague and non-plague Yersinia infections. Eur J Clin Microbiol Infect Dis. 1999;18(1):1-15.
14. Runfola JK, House J, Miller L, Colton L, Hite D, Hawley A, et al. Outbreak of Human Pneumonic Plague with Dog-to-Human and Possible Human-to-Human Transmission-Colorado, June-July 2014. MMWR Morb Mortal Wkly Rep. 2015;64(16):429-34.
15. Perry RD, Fetherston JD. Yersinia pestis: etiologic agent of plague. Clin Microbiol Rev. 1997;10(1):35-66.
16. Dawa W, Pan WJ, Gu XY, Zhang SQ, Dawa C, Yi X, et al. Clinical features, diagnosis and treatment of 5 cases of primary pneumonic plague in Tibet in 2010. Chin J Tuberc Respir Dis. 2011;34(6):404-8.
17. Wei SZ, He DL, Li C, Ning G, Wei BQ, Yu SH, et al. The first pathological findings analysis of pneumonic plague deaths in Xinghai county in Qinghai province in 2009. Chin J Endemiol. 2010;29(5):588.
18. Singhi S, Dhawan A. Frequency and significance of electrolyte abnormalities in pneumonia. Indian Pediatr. 1992;29(6):735-40.
19. Ber R, Mamroud E, Aftalion M, Tidhar A, Gur D, Flashner Y, et al. Development of an improved selective agar medium for isolation of Yersinia pestis. Appl Environ Microbiol. 2003;69(10):5787-92.
20. Stock I. Yersinia pestis and plague - an update. Med Monatsschr Pharm. 2014;37(12):441-8. quiz 449.
21. Koster F, Perlin DS, Park S, Brasel T, Gigliotti A, Barr E, et al. Milestones in progression of primary pneumonic plague in cynomolgus macaques. Infect Immun. 2010;78(7):2946-55.
22. Tsui PY, Tsai HP, Chiao J, Liu CC, Shyu RH. Rapid detection of Yersinia pestis recombinant fraction 1 capsular antigen. Appl Microbiol Biotechnol. 2015;99(18):7781-9.
23. Williams JE, Arntzen L, Robinson DM, Cavanaugh DC, Isaäcson M. Comparison of passive haemagglutination and enzymelinked immunosorbent assay for serodiagnosis of plague. Bull World Health Organ. 1982;60(5):777-8.
24. Loïez C, Herwegh S, Wallet F, Armand S, Guinet F, Courcol RJ. Detection of Yersinia pestis in sputum by real-time PCR. J Clin Microbiol. 2003;41(10):4873-5.
25. Rasoamanana B, Leroy F, Boisier P, Rasolomaharo M, Buchy P, Carniel E, et al. Field evaluation of an IgG anti-F1 ELISA test for the serodiagnosis of human plague in Madagascar. Clin Diagn Lab Immunol. 1997;4(5):587-91.
26. Splettstoesser WD, Rahalison L, Grunow R, Neubauer H, Chanteau S. Evaluation of a standardized F1 capsular antigen capture ELISA test kit for the rapid diagnosis of plague. FEMS Immunol Med Microbiol. 2004;41(2):149-55.
27. Wei H, Zhao Y, Bi Y, Liu H, Guo Z, Song Y, et al. Direct detection of Yersinia pestis from the infected animal specimens by a fiber optic biosensor. Sens Actuators B Chem. 2007;123(1):204-10.
28. Cao LK, Anderson GP, Ligler FS, Ezzell J. Detection of Yersinia pestis fraction 1 antigen with a fiber optic biosensor. J Clin Microbiol. 1995;33(2):336-41.
29. Schaffer FL, Soergel ME, Williams JE. Antibody response to plague vaccination in humans as assayed by staphylococcal radioimmune precipitation (St-RIP) test. J Biol Stand. 1981;9(3):265-76.
30. Plague in Madagascar Available at http://www.who.int/csr/disease/plague/madagascar-outbreak/en/.
31. Plague manual--epidemiology, distribution, surveillance and control. Wkly Epidemiol Rec. 1999;74(51-52):447
32. Peterson JW, Moen ST, Healy D, Pawlik JE, Taormina J, Hardcastle J, et al. Protection Afforded by Fluoroquinolones in Animal Models of Respiratory Infections with Bacillus anthracis, Yersinia pestis, and Francisella tularensis. Open Microbiol J. 2010;3(4):34-46.
33. Wendte JM, Ponnusamy D, Reiber D, Blair JL, Clinkenbeard KD. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis. Antimicrob Agents Chemother. 2011;55(8):3752-7.
34. Chinese CDC. Plague diagnosis scheme (on trial). Available at http://www.chinacdc.cn/jkzt/crb/sy/jszl_2217/201111/t20111117_54777.htm. November 2011.
35. Finegold SM, Davis A. Antibiotics and antibacterials, general. Calif Med. 1969;111(5):364-73.
36. Mwengee W, Butler T, Mgema S, Mhina G, Almasi Y, Bradley C, et al. Treatment of plague with gentalmicin or doxycycline in a randomized clinical trial in Tanzania. Clin Infect Dis. 2006;42(5):614-21.
37. Boulanger LL, Ettestad P, Fogarty JD, Dennis DT, Romig D, Mertz G. Gentamicin and tetracyclines for the treatment of human plague: review of 75 cases in new Mexico, 1985-1999. Clin Infect Dis. 2004;38(5):663-9.
38. Plague. Available at http://www.who.int/csr/disease/plague/en/.
39. Lemaître N, Ricard I, Pradel E, Foligné B, Courcol R, Simonet M, et al. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague. PLoS ONE. 2012;7(12), e52503.
40. Rosenzweig JA, Brackman SM, Kirtley ML, Sha J, Erova TE, Yeager LA, et al. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin. Antimicrob Agents Chemother. 2011;55(11):5034-42.
41. Galimand M, Carniel E, Courvalin P. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob Agents Chemother. 2006;50(10):3233-6.
42. Anisimov AP, Amoako KK. Treatment of plague: promising alternatives to antibiotics. J Med Microbiol. 2006;55(Pt 11):1461-75.